Surgery Partners Inc. (SGRY)
Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain
Surgery Partners (SGRY) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Surgery Partners (SGRY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
Surgery Partners (SGRY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago.
8 Knots Management LLC Takes Position in Surgery Partners, Inc. $SGRY
8 Knots Management LLC acquired a new position in Surgery Partners, Inc. (NASDAQ: SGRY) during the undefined quarter, according to its most recent filing with the SEC. The fund acquired 220,088 shares of the company's stock, valued at approximately $4,763,000. Surgery Partners makes up about 0.5% of 8 Knots Management LLC's holdings, making
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
Surgery Partners (SGRY) Lags Q4 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.44 per share a year ago.
Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last?
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Surgery Partners, Inc. (SGRY) Q3 2025 Earnings Call Transcript
Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Ryan Langston - TD Cowen, Research Division Presentation Operator Greetings, and welcome to the Surgery Partners' Third Quarter 2025 Earnings Call.
Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.
